Literature DB >> 24427353

Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.

Ni Wang1, Chao-Ran Dong1, Rong Jiang2, Cui Tang1, Lei Yang1, Qi-Feng Jiang1, George G Chen3, Zhi-Min Liu1.   

Abstract

Hypoxia inducible factor-1α (HIF-1α) is upregulated by hypoxia, and involved in tumor growth and metastasis in many malignant tumors including papillary thyroid carcinoma (PTC). Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. SLUG is a member of SNAIL superfamily of zinc finger transcriptional factors implicated in epithelial-mesenchymal transition (EMT). The purpose of this study was to examine HIF-1α, MT and SLUG expression in PTC and assess association of their expression with clinicopathological indicators. HIF-1α, MT and SLUG protein expression in 129 PTCs, 61 nodular hyperplasia and 118 normal thyroid tissue specimens were analyzed using immunohistochemistry. The protein expression levels of these three molecules were up-regulated in PTCs. High protein expression of HIF-1α, MT and SLUG was significantly correlated with high TNM stage (P=0.003, 0.002, 0.024, respectively) and lymph node metastasis (LNM) (P<0.001 for all three molecules). Furthermore, HIF-1α, MT and SLUG protein expression were correlated with one another. Concomitant high expression of any two of these three molecules had stronger correlation with high TNM stage (P≤0.001 for HIF-1α/MT, MT/SLUG and HIF-1α/SLUG) and LNM (P=0.008, 0.002, 0.019 for HIF-1α/MT, MT/SLUG and HIF-1α/SLUG, respectively) than did each alone, and concomitant high expression of all these three molecules is significantly associated with high TNM stage and LNM as compared with cases not showing such expression (P<0.001). These results demonstrated that the evaluation of HIF-1α, MT and SLUG expression in PTC may be useful in predicting the risk of LNM and high TNM stage.

Entities:  

Keywords:  Hypoxia inducible factor-1α; SLUG; metallothionein; papillary thyroid carcinoma

Mesh:

Substances:

Year:  2013        PMID: 24427353      PMCID: PMC3885487     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

Review 1.  The elusive function of metallothioneins.

Authors:  R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 2.  Staging systems for papillary thyroid carcinoma: a review and comparison.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

3.  Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.

Authors:  Chi-Hung Huang; Wen-Hao Yang; Shyue-Yih Chang; Shyh-Kuan Tai; Cheng-Hwei Tzeng; Jung-Yie Kao; Kou-Juey Wu; Muh-Hwa Yang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney.

Authors:  Ichiro Kojima; Tetsuhiro Tanaka; Reiko Inagi; Hiroshi Nishi; Hiroyuki Aburatani; Hideki Kato; Toshio Miyata; Toshiro Fujita; Masaomi Nangaku
Journal:  Kidney Int       Date:  2008-10-01       Impact factor: 10.612

5.  Snail family transcription factors are implicated in thyroid carcinogenesis.

Authors:  Robert G Hardy; Carolina Vicente-Dueñas; Ines González-Herrero; Catriona Anderson; Teresa Flores; Sharon Hughes; Chris Tselepis; James A Ross; Isidro Sánchez-García
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

6.  Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha.

Authors:  Brian J Murphy; Tomoki Kimura; Barbara G Sato; Yihui Shi; Glen K Andrews
Journal:  Mol Cancer Res       Date:  2008-03       Impact factor: 5.852

7.  The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.

Authors:  G Storci; P Sansone; D Trere; S Tavolari; M Taffurelli; C Ceccarelli; T Guarnieri; P Paterini; M Pariali; L Montanaro; D Santini; P Chieco; M Bonafé
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 8.  Metallothioneins and cancer.

Authors:  Tomas Eckschlager; Vojtech Adam; Jan Hrabeta; Katarina Figova; Rene Kizek
Journal:  Curr Protein Pept Sci       Date:  2009-08       Impact factor: 3.272

Review 9.  The role of hypoxia-inducible factors in tumorigenesis.

Authors:  E B Rankin; A J Giaccia
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

Review 10.  Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers.

Authors:  Catarina Castro Alves; Fatima Carneiro; Heinz Hoefler; Karl-Friedrich Becker
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  17 in total

1.  Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

Authors:  C Visciano; F Liotti; N Prevete; G Cali'; R Franco; F Collina; A de Paulis; G Marone; M Santoro; R M Melillo
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

2.  Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.

Authors:  Zeming Liu; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Yusufu Maiaiti; Shuntao Wang; Haiping Song; Lan Shi; Chunping Liu; Bo Cheng; Bo Zhang; Jie Ming; Fang Dong; Hui Ge; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.

Authors:  Ningning Liu; Yizhou Sun; Ning Zhao; Lei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.

Authors:  Zeming Liu; Xiaoyu Li; Lan Shi; Yusufu Maimaiti; Tianwen Chen; Zhi Li; Shuntao Wang; Yiquan Xiong; Hui Guo; Wenshan He; Chunping Liu; Xiu Nie; Wen Zeng; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

5.  The tumor-promoting function of ECRG4 in papillary thyroid carcinoma and its related mechanism.

Authors:  Jiayu Chen; Chibo Liu; Lihui Yin; Wei Zhang
Journal:  Tumour Biol       Date:  2014-10-19

Review 6.  Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis.

Authors:  Calen A Steiner; Ian M Cartwright; Cormac T Taylor; Sean P Colgan
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

7.  Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury.

Authors:  Xin Zhao; Yanwu Jin; Haibo Li; Zhigang Wang; Wanlin Zhang; Chang Feng
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.

Authors:  Guannan Zhao; Yuqi Guo; Zixuan Chen; Yinan Wang; Chuanhe Yang; Andrew Dudas; Ziyun Du; Wen Liu; Yanan Zou; Erzsebet Szabo; Sue-Chin Lee; Michelle Sims; Weiwang Gu; Todd Tillmanns; Lawrence M Pfeffer; Gabor Tigyi; Junming Yue
Journal:  J Cancer Sci Ther       Date:  2015

Review 9.  Tumor-Associated Mast Cells in Thyroid Cancer.

Authors:  Carla Visciano; Nella Prevete; Federica Liotti; Gianni Marone
Journal:  Int J Endocrinol       Date:  2015-08-26       Impact factor: 3.257

10.  Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.

Authors:  Samira M Sadowski; Myriem Boufraqech; Lisa Zhang; Amit Mehta; Payal Kapur; Yaqin Zhang; Zhuyin Li; Min Shen; Electron Kebebew
Journal:  Oncotarget       Date:  2015-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.